New online program eases Kids' cancer return to school

NCT ID NCT06389357

Completed Symptom relief Sponsor: Gazi University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a web-based program to help children aged 8-17 with cancer adjust to returning to school. The program included modules for children, parents, teachers, and peers, focusing on communication, coping, and social skills. Twenty children participated, and researchers measured social anxiety, coping strategies, and school readiness. The goal was to see if the program is feasible and helpful, with the aim of creating a sustainable support model.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: web-based training and counselling program
What this could lead to: If it works, this could provide a practical, scalable way to help children with cancer feel less anxious and more prepared when going back to school.
What could go wrong: This was a very small study (20 participants) with no control group, so results may not apply to all children. The program's long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALL, CHILDHOOD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia childhood acute lymphoblastic leukemia childhood acute myeloid leukemia childhood malignant neoplasm childhood neoplasm leukemia lymphoma neoplasm Precursor Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALL, CHILDHOOD AML, CHILDHOOD CHILDHOOD CANCER LYMPHOMA SOLID TUMOR, CHILDHOOD

Contacts and locations

Locations

Gizem Cakir

Ankara, Cankaya, 06490, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.